16 Jul 2020 --- The Chinese nutrition market is increasingly lucrative, as evident by Danone’s €100 million (US$114 million) investment in its Specialized Nutrition business in the country. The funding will facilitate the opening of a research center based in Shanghai, boost the company’s local infant milk formula capabilities and expand its capacity to further develop offerings in Food for Special Medical Purposes (FSMP). In addition, the company’s Early Life Nutrition business unit in China recently achieved B Corp certification, making it the biggest B Corp in Asia.
